We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBOE icon
226
Cboe Global Markets
CBOE
$32.2B
$12.8M 0.08%
69,725
+59,034
+552% +$10.9M
KMB icon
227
Kimberly-Clark
KMB
$37.6B
$12.5M 0.08%
96,821
+3,618
+4% +$444K
DAY
228
DELISTED
Dayforce
DAY
$12.5M 0.08%
188,866
-61,907
-25% -$4.23M
ULTA icon
229
Ulta Beauty
ULTA
$21.8B
$12.5M 0.08%
23,885
+7,042
+42% +$3.64M
LKQ icon
230
LKQ Corp
LKQ
$6.72B
$12.5M 0.08%
233,547
+12,078
+5% +$599K
LEGN icon
231
Legend Biotech
LEGN
$3.65B
$12.4M 0.08%
221,032
-20,000
-8% -$1.21M
IMCR icon
232
Immunocore
IMCR
$1.7B
$12.3M 0.08%
189,006
+45,000
+31% +$3.09M
CAT icon
233
Caterpillar
CAT
$361B
$12.1M 0.08%
33,098
-68,559
-67% -$21.9M
HPE icon
234
Hewlett Packard
HPE
$58.8B
$12.1M 0.08%
683,971
-33,829
-5% -$549K
MLTX icon
235
MoonLake Immunotherapeutics
MLTX
$1.56B
$12M 0.08%
239,000
+54,000
+29% +$2.93M
ORCL icon
236
Oracle
ORCL
$339B
$12M 0.08%
95,406
+5,355
+6% +$613K
PLD icon
237
Prologis
PLD
$136B
$11.9M 0.08%
91,218
-125,948
-58% -$16.5M
LEA icon
238
Lear
LEA
$7.39B
$11.8M 0.08%
81,679
+834
+1% +$114K
BBIO icon
239
BridgeBio Pharma
BBIO
$16.4B
$11.7M 0.08%
380,000
+81,000
+27% +$2.75M
LH icon
240
Labcorp
LH
$25.2B
$11.7M 0.08%
53,725
+32,083
+148% +$7.07M
ITT icon
241
ITT
ITT
$17.1B
$11.7M 0.07%
85,910
– –
ROP icon
242
Roper Technologies
ROP
$40.4B
$11.1M 0.07%
19,776
+2,147
+12% +$1.17M
TXN icon
243
Texas Instruments
TXN
$248B
$10.7M 0.07%
61,180
-36,405
-37% -$6.07M
SHOP icon
244
Shopify
SHOP
$168B
$10.7M 0.07%
137,979
+3,105
+2% +$245K
TMUS icon
245
T-Mobile US
TMUS
$195B
$10.6M 0.07%
65,225
+9,332
+17% +$1.52M
WTRG icon
246
Essential Utilities
WTRG
$11.5B
$10.6M 0.07%
286,102
+41,422
+17% +$1.5M
INSM icon
247
Insmed
INSM
$22.4B
$10.6M 0.07%
390,200
+80,000
+26% +$2.24M
PTGX icon
248
Protagonist Therapeutics
PTGX
$8.55B
$10.4M 0.07%
360,000
-177,000
-33% -$4.82M
C icon
249
Citigroup
C
$213B
$10.4M 0.07%
163,949
-5,953
-4% -$331K
EG icon
250
Everest Group
EG
$15.6B
$10.3M 0.07%
26,032
-17,676
-40% -$6.63M
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.